-+ 0.00%
-+ 0.00%
-+ 0.00%

Chimerix Shares Top 52-week Highs, Company Plans FDA Submission of Cancer Drug Dordaviprone

Dow Jones·12/09/2024 22:15:00

Please log in to view news